Primitive neuroectodermal tumor incidence, treatment patterns, and outcome: An analysis of the National Cancer Database
Internal Medicine (East Africa)
Background: Primitive neuroectodermal tumors (PNETs) comprise less than 1% of all sarcomas. The rarity of this disease has resulted in a paucity of information about disease process and management. This study sought to evaluate the incidence, treatment patterns, and outcomes among patients with PNET.
Methods: The National Cancer Database was queried for diagnoses of PNET between 2004 and 2014. Patients were dichotomized based on tumor type (central [cPNET] vs peripheral [pPNET]). Demographic, tumor, treatment, and outcome variables were analyzed for the entire patient cohort and by type of PNET.
Results: White (86.4%) males (56.6%) represented the majority of patients. The incidence of PNET remained stable over the study period (r2 = 0.0821). A total of 70.7% underwent surgical resection of the primary site, 50.3% received radiation, and 74.7% received systemic chemotherapy. Compared to those with pPNET, patients with cPNET more often received radiation treatment (P < .001), primary tumor resection (P < .001), and experienced increased 90‐day mortality (P < .014).
Conclusion: cPNET and pPNET are rare and aggressive malignancies that tend to arise in White males. Multimodal treatment including surgery, chemotherapy, and radiation is conventional. Patients with cPNET more often receive radiation and primary tumor resection with increased 90‐day mortality.
Journal of Surgical Oncology
Woeste, M. R.,
Hong, Y. K.,
Egger, M. E.,
McMasters, K. M.,
Martin, R. C.,
Scoggins, C. R.
(2020). Primitive neuroectodermal tumor incidence, treatment patterns, and outcome: An analysis of the National Cancer Database. Journal of Surgical Oncology, 122(6), 1145-1151.
Available at: https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med/209